Joy is a Partner at Forbion and joined in 2023 to establish and co-lead Forbion's BioEconomy strategy.
Before joining Forbion, Joy invested in growth and early stage companies at Lightrock, MVentures (Merck's CVC) and as an angel. He has also held operational positions at Formo and Eli Lilly's biotech commercial launch facility. Prior investments include Sunfire, Kebony, Galy, Phagos and Living Carbon.
Joy holds a Master’s in Bioscience Enterprise from the University of Cambridge, and a Bachelor’s in Biochemical Engineering from University College London.

Biotechnology is powerful tool that when scaled can deliver meaningful impact to planetary health. At Forbion, we work with founders that are deploying exciting science in a real world context within critical sectors that are in dire need for systemic change.